Can trazodone (antidepressant) or buspirone (anxiolytic) cause a urine drug screen (UDS) to test positive for amphetamines in patients with a history of mental health issues?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Trazodone or Buspirone Cause False-Positive Amphetamine Results on Urine Drug Screens?

Trazodone frequently causes false-positive amphetamine results on urine drug screens through cross-reactivity of its metabolite m-chlorophenylpiperazine (m-CPP), while buspirone does not cause false-positive amphetamine results. 1, 2

Trazodone and False-Positive Amphetamine Screens

Mechanism and Frequency

  • Trazodone's primary metabolite, m-chlorophenylpiperazine (m-CPP), directly cross-reacts with amphetamine immunoassays, particularly the commonly used Roche Amphetamines II and Thermo Scientific DRI assays 2, 3
  • This interference occurs frequently in clinical practice—one institution documented at least 8 trazodone-associated false-positive amphetamine results during a single 26-day period 2
  • The degree of cross-reactivity correlates strongly with m-CPP concentration in urine (correlation coefficient r = 0.990), meaning higher trazodone doses or recent administration increases false-positive likelihood 2

Critical Clinical Actions

  • Order confirmatory testing using gas chromatography-mass spectrometry (GC-MS) immediately before making any clinical decisions based on a positive amphetamine screen in patients taking trazodone 1
  • Obtain a complete medication history specifically asking about trazodone use when interpreting any positive amphetamine/methamphetamine result 1
  • Never discharge patients from practice or make punitive decisions based solely on immunoassay screening results without confirmatory testing 1

Buspirone and Amphetamine Screens

  • Buspirone is not identified in the medical literature as causing false-positive amphetamine results on urine drug screens 4, 5, 6
  • The medications documented to cause false-positive amphetamine screens include: brompheniramine, bupropion, chlorpromazine, dextromethorphan, promethazine, quetiapine, ranitidine, trazodone, and verapamil—but not buspirone 4

Differential Diagnosis for Positive Amphetamine Screens

When encountering a positive amphetamine screen in a patient denying use, consider:

  • False-positive from trazodone (m-CPP cross-reactivity) 1, 2
  • Actual amphetamine/methamphetamine use (prescribed or illicit) 1
  • Other medication interferences (bupropion, pseudoephedrine, ranitidine) 4
  • Laboratory error 1
  • Self-treatment of uncontrolled psychiatric symptoms 7

Essential Pitfalls to Avoid

  • Assuming all positive amphetamine screens represent illicit drug use is incorrect, as multiple prescribed medications cause false positives 1
  • Failing to recognize that standard enzyme-linked immunoassays are screening tests only with known specificity limitations leads to misinterpretation 1
  • Many healthcare providers have inadequate training in interpreting urine drug test results, and incorrect interpretation can have severe consequences including legal implications 7, 1
  • False-positive laboratory results are 8 times more frequent than true positives (1.8%) in patients with routine testing 7

Recommended Testing Approach

  • Establish a working relationship with your local toxicologist for consultation on complex results 7, 1
  • Confirmatory testing with GC-MS is required to definitively identify specific substances when results are unexpected or will impact clinical decisions 1, 4
  • Discuss unexpected positive results promptly with the patient in a non-judgmental manner before taking action, keeping in mind the possibility of false-positive results 7

References

Guideline

Trazodone-Associated False Positives in Drug Screens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Commonly prescribed medications and potential false-positive urine drug screens.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.